Cargando…

Gut Microbiome–Dependent Metabolic Pathways and Risk of Lethal Prostate Cancer: Prospective Analysis of a PLCO Cancer Screening Trial Cohort

BACKGROUND: Diet and the gut microbiome have a complex interaction that generates metabolites with an unclear effect on lethal prostate cancer risk. Identification of modifiable risk factors for lethal prostate cancer is challenging given the long natural history of this disease and difficulty of pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reichard, Chad A., Naelitz, Bryan D., Wang, Zeneng, Jia, Xun, Li, Jianbo, Stampfer, Meir J., Klein, Eric A., Hazen, Stanley L., Sharifi, Nima
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Association for Cancer Research 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8755576/ https://www.ncbi.nlm.nih.gov/pubmed/34711629 http://dx.doi.org/10.1158/1055-9965.EPI-21-0766

Ejemplares similares

Seropositivity for Helicobacter pylori and hepatobiliary cancers in the PLCO study
por: Makkar, Rishi, et al.
Publicado: (2020)

Coffee, tea, caffeine intake, and the risk of cancer in the PLCO cohort
por: Hashibe, Mia, et al.
Publicado: (2015)

Aspirin but not ibuprofen use is associated with reduced risk of prostate cancer: a PLCO Study
por: Shebl, F M, et al.
Publicado: (2012)

Dairy Product Consumption and Bladder Cancer Risk in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cohort
por: Xu, Xin
Publicado: (2020)

Prediction of future risk of any and higher-grade prostate cancer based on the PLCO and SELECT trials
por: Gelfond, Jonathan A., et al.
Publicado: (2022)

Body mass index (BMI) trajectories and risk of colorectal cancer in the PLCO cohort
por: Zheng, Rui, et al.
Publicado: (2018)

Circulating Insulin-Like Growth Factor 1–Related Biomarkers and Risk of Lethal Prostate Cancer
por: Ma, Chaoran, et al.
Publicado: (2021)

Weight Change and Incident Distal Colorectal Adenoma Risk in the PLCO Cancer Screening Trial
por: He, Shisi, et al.
Publicado: (2022)

The impact of folate intake on the risk of head and neck cancer in the prostate, lung, colorectal, and ovarian cancer screening trial (PLCO) cohort
por: Kawakita, Daisuke, et al.
Publicado: (2018)

White blood cell DNA methylation and risk of breast cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO)
por: Sturgeon, Susan R., et al.
Publicado: (2017)

Prospective study of the relationship between coffee and tea with colorectal cancer risk: The PLCO Cancer Screening Trial
por: Dominianni, C, et al.
Publicado: (2013)

Body mass index and mortality among blacks and whites in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
por: Xiao, Qian, et al.
Publicado: (2013)

Integrative Genomic Analysis Reveals Extended Germline Homozygosity with Lung Cancer Risk in the PLCO Cohort
por: Orloff, Mohammed S., et al.
Publicado: (2012)

Breast cancer epidemiology according to recognized breast cancer risk factors in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial Cohort
por: Lacey, James V, et al.
Publicado: (2009)

Recalibrating Risk Prediction Models by Synthesizing Data Sources: Adapting the Lung Cancer PLCO Model for Taiwan
por: Chien, Li-Hsin, et al.
Publicado: (2022)

Associations between obesity, smoking and lymph node status at breast cancer diagnosis in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
por: Smith, Amelia, et al.
Publicado: (2018)

Serum α-Tocopherol and γ-Tocopherol Concentrations and Prostate Cancer Risk in the PLCO Screening Trial: A Nested Case-Control Study
por: Weinstein, Stephanie J., et al.
Publicado: (2012)

Detection method has independent prognostic significance in the PLCO lung screening trial
por: Long, James P., et al.
Publicado: (2023)

Time to First Morning Cigarette and Risk of Chronic Obstructive Pulmonary Disease: Smokers in the PLCO Cancer Screening Trial
por: Guertin, Kristin A., et al.
Publicado: (2015)

Relationship between prediagnostic body mass index trajectory and colorectal adenomas: an analysis of the PLCO cancer screening trial
por: Luo, Linna, et al.
Publicado: (2020)

Applying precision medicine to the active surveillance of prostate cancer
por: Reichard, Chad A., et al.
Publicado: (2015)

Association between soft drink consumption types and risk of lung cancer and all-cancer: A prospective study of PLCO data
por: You, Dongfang, et al.
Publicado: (2022)

Evaluation of the Lung Cancer Risks at Which to Screen Ever- and Never-Smokers: Screening Rules Applied to the PLCO and NLST Cohorts
por: Tammemägi, Martin C., et al.
Publicado: (2014)

US gynecologists’ estimates and beliefs regarding ovarian cancer screening’s effectiveness 5 years after release of the PLCO evidence
por: Wegwarth, Odette, et al.
Publicado: (2018)

Development of a gut microbe-targeted non-lethal therapeutic to inhibit thrombosis potential
por: Roberts, Adam B., et al.
Publicado: (2018)

Correction: Evaluation of the Lung Cancer Risks at Which to Screen Ever- and Never-Smokers: Screening Rules Applied to the PLCO and NLST Cohorts
Publicado: (2015)

Fecal Microbiome Composition Does Not Predict Diet‐Induced TMAO Production in Healthy Adults
por: Ferrell, Marc, et al.
Publicado: (2021)

The effects of the Green-Mediterranean diet on cardiometabolic health are linked to gut microbiome modifications: a randomized controlled trial
por: Rinott, Ehud, et al.
Publicado: (2022)

Analysis of lung cancer risk model (PLCO(M2012) and LLP(v2)) performance in a community-based lung cancer screening programme
por: Lebrett, Mikey B, et al.
Publicado: (2020)

Genetic variants of genes in the Notch signaling pathway predict overall survival of non-small cell lung cancer patients in the PLCO study
por: Xu, Yinghui, et al.
Publicado: (2016)

OWL: an optimized and independently validated machine learning prediction model for lung cancer screening based on the UK Biobank, PLCO, and NLST populations
por: Pan, Zoucheng, et al.
Publicado: (2023)

Immune protection is dependent on the gut microbiome in a lethal mouse gammaherpesviral infection
por: Yaron, Jordan R., et al.
Publicado: (2020)

GWAS Explorer: an open-source tool to explore, visualize, and access GWAS summary statistics in the PLCO Atlas
por: Machiela, Mitchell J., et al.
Publicado: (2023)

Emerging Relationship between the Gut Microbiome and Prostate Cancer
por: Matsushita, Makoto, et al.
Publicado: (2023)

Chocolate consumption and all-cause and cause-specific mortality in a US population: a post hoc analysis of the PLCO cancer screening trial
por: Zhong, Guo-Chao, et al.
Publicado: (2021)

Prostate cancer polygenic risk score and prediction of lethal prostate cancer
por: Klein, Robert J., et al.
Publicado: (2022)

The Gut-Prostate Axis: A New Perspective of Prostate Cancer Biology through the Gut Microbiome
por: Fujita, Kazutoshi, et al.
Publicado: (2023)

Evaluation of the accuracy of the PLCO(m2012) 6-year lung cancer risk prediction model among smokers in the CARTaGENE population-based cohort
por: Jantzen, Rodolphe, et al.
Publicado: (2023)

Body weight trajectories and risk of oesophageal and gastric cardia adenocarcinomas: a pooled analysis of NIH-AARP and PLCO Studies
por: Petrick, Jessica L, et al.
Publicado: (2017)

Editorial: The development of lethal prostate cancer
por: Zhang, Baotong, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qkusmus06alish2rf6bqveikma